Influence of the ultrasound contrast agent Levovist((R)) on human nailfoldcapillary microcirculation

Citation
Ff. Immer et al., Influence of the ultrasound contrast agent Levovist((R)) on human nailfoldcapillary microcirculation, ANGIOLOGY, 51(2), 2000, pp. 123-129
Citations number
25
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
ANGIOLOGY
ISSN journal
00033197 → ACNP
Volume
51
Issue
2
Year of publication
2000
Pages
123 - 129
Database
ISI
SICI code
0003-3197(200002)51:2<123:IOTUCA>2.0.ZU;2-L
Abstract
Little is known about the behavior of ultrasound contrast microbubbles in h uman capillaries. The evaluation of circulatory effects of echo contrast me dia may bring valuable information for the interpretation of echo contrast phenomena in the human myocardium. In 12 healthy volunteers (aged 31 +/- 6. 7 years; five women), nailfold capillaries were examined by means of TV mic roscopy, The authors investigated acral microcirculation at rest and after local cold application with and without saccharide-based microbubbles (10 m L Levovist(R) 300 mg/mL IV), The mean blood flow velocity at rest was 1.18 +/- 0.18 mm/s (mean value +/- 1 SD) and 1.11 +/- 0.11 mm/s (mean value +/- 1 SD) after the injection of Levovist(R) (ns). One minute after local cold exposure a decrease of the blood flow velocity by 61% before and by 75% aft er intravenous Levovist(R) was found. In both groups the cold-induced decre ase of blood flow velocity was statistically significant (p<0.01), whereas there was no significant difference in flow reaction between the two groups . No wall adhesion of blood cells or extravasation of contrast into the sur rounding tissue was detected. After intravenous injection of a regular dose of saccharide-based microbubbles Levovist(R), no change of blood cell flow velocity and no wall adhesion or extravasation could be found at rest and after cold application in human nailfold capillaries. Since microcirculator y flow characteristics in the finger nailfold capillaries are not influence d by Levovist(R), it might be assumed also that myocardial blood flow behav ior remains unchanged, so that this contrast agent may be used as a flow tr acer for cardiac investigation.